Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr1286 Inhibitors

Olr1286 inhibitors are a distinct class of chemical compounds specifically designed to target and inhibit the Olr1286 receptor, which is an olfactory receptor belonging to the G protein-coupled receptor (GPCR) superfamily. These receptors play a vital role in the olfactory system, which is responsible for detecting and interpreting odorant molecules, thereby contributing to the sense of smell. Olr1286 inhibitors function by binding to the receptor's active site or other crucial binding regions, effectively blocking the receptor's ability to interact with its natural ligands. This binding prevents the receptor from undergoing the necessary conformational changes that trigger intracellular signaling pathways, thereby disrupting the transmission of olfactory signals. The design and development of Olr1286 inhibitors often rely on detailed structural analyses of the receptor, using techniques such as X-ray crystallography, molecular modeling, and cryo-electron microscopy. These techniques provide crucial insights into the receptor's binding sites and other structural features, enabling the creation of inhibitors that are highly specific and effective in modulating the activity of the Olr1286 receptor.

Chemically, Olr1286 inhibitors exhibit a wide range of molecular structures, reflecting the diversity of approaches used in their synthesis. These inhibitors can range from small, lipophilic molecules that can easily penetrate cellular membranes to larger, more complex molecules that may require advanced synthetic techniques to achieve optimal binding affinity and specificity. The synthesis of Olr1286 inhibitors typically involves multiple steps of organic synthesis, including the formation of molecular frameworks and the incorporation of functional groups that enhance binding interactions with the receptor. Once synthesized, these compounds undergo rigorous characterization using analytical techniques such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry, and high-performance liquid chromatography (HPLC). These methods are employed to verify the structural integrity, purity, and inhibitory activity of the compounds. The study of Olr1286 inhibitors is important for understanding the specific mechanisms by which this olfactory receptor functions and how its activity can be modulated by small molecules. Additionally, this research contributes to a broader understanding of GPCR modulation, offering valuable insights into the complex biochemical processes underlying sensory perception, particularly in the context of olfaction.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

Src family kinase inhibitor, potentially altering cell proliferation and survival pathways affecting Olr1286.

Erlotinib Hydrochloride

183319-69-9sc-202154
sc-202154A
10 mg
25 mg
$75.00
$121.00
33
(1)

EGFR tyrosine kinase inhibitor, might disrupt signaling pathways that influence Olr1286 activity.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

EGFR inhibitor, could alter cell growth and differentiation pathways relevant to Olr1286.

Lapatinib

231277-92-2sc-353658
100 mg
$420.00
32
(1)

Dual EGFR and HER2 inhibitor, potentially modulating signaling pathways relevant to Olr1286's function.

Nilotinib

641571-10-0sc-202245
sc-202245A
10 mg
25 mg
$209.00
$413.00
9
(1)

BCR-ABL kinase inhibitor, might impact cell proliferation and survival pathways influencing Olr1286.

Palbociclib

571190-30-2sc-507366
50 mg
$321.00
(0)

CDK4/6 inhibitor, could modulate cell cycle regulation pathways impacting Olr1286.

Pazopanib

444731-52-6sc-396318
sc-396318A
25 mg
50 mg
$130.00
$182.00
2
(1)

Inhibits multiple tyrosine kinases, potentially affecting pathways influencing Olr1286, like angiogenesis or cell proliferation.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Multi-kinase inhibitor, might disrupt several signaling pathways involving Olr1286.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$153.00
$938.00
5
(0)

Multi-targeted receptor tyrosine kinase inhibitor, could alter signaling pathways impacting Olr1286's activity.